Where Should a Pharma or Traceability Company Start with AI? A Realistic Roadmap
This is the question that matters most, and the one where I’ve seen the most money wasted. The good news: the failure patterns are well known and avoidable. The starting point is never the technology.
Start from pain, not from AI. List your top operational problems with a quantifiable cost: false-reject rates on inspection lines, unplanned downtime on critical equipment, hours spent manually investigating supply chain exceptions, slow deviation handling. AI is a means; if a problem can be solved with better rules or better process, solve it that way and save your AI budget for problems that genuinely need learning from data.
Assess data readiness honestly. For each candidate use case, ask: does data containing the relevant signal exist? Is it accessible, or trapped in isolated systems? Is there ground truth – labels, confirmed outcomes, maintenance records? A brilliant use case with no data loses to a modest use case with excellent data, every time
Pick a first project with three properties: measurable value (a KPI you can show a CFO), contained risk (decision-support, not autonomous control, in your first iteration), and available data. Classic strong candidates in our field: anomaly detection on serialization event flows, AI-assisted classification of borderline inspection images, first-level predictive monitoring on critical line components, LLM-assisted documentation search.
Design the human loop from day one. Who reviews the model’s uncertain cases? Who confirms outcomes? That feedback is both your safety net and your future training data. Projects that skip this die at the pilot stage.
Plan for the lifecycle, not the demo. Budget and assign ownership for monitoring, drift detection, retraining, and revalidation before go-live. A model without an operational owner is technical debt with a nice dashboard.
Invest in literacy across functions. The most successful adoptions I’ve seen were not the ones with the most sophisticated models, but the ones where quality, operations, IT, and management shared a realistic common understanding of what AI can and cannot do – which is precisely the purpose of this Q&A series.
The timeline: a well-chosen first project can show measurable value in months, not years. The compounding asset is not the model – it is the data discipline and organizational capability you build along the way. Companies that treat the first project as a learning investment, rather than a magic bullet, are the ones still doing AI successfully three years later.
